Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
Open accessThe DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the frequency of continuous glucose monitoring (CGM) device use, factors associated with its use, and the relationship of CGM with diabetes outcomes (HbA1c, severe hypoglycemia [SH], and diabetic ketoacidosis [DKA]). RESEARCH DESIGN AND METHODS: Survey questions related to CGM device use 1 year after enrollment in the T1D Exchange clinic registry were completed by 17,317 participants. Participants were defined as CGM users if they indicated using real-time CGM during the prior 30 days. RESULTS: Nine percent of participants used CGM (6% of children <13 years old, 4% of adolescents 13 to <18 years, 6% of young adults 18 to <26 years, and 21% of adults ≥26 years). CGM use was more likely with higher education, higher household income, private health insurance, longer duration of diabetes, and use of insulin pump (P < 0.01 all factors). CGM use was associated with lower HbA1c in children (8.3% vs. 8.6%, P < 0.001) and adults (7.7% vs. 7.9%, P < 0.001). In adults, more frequent use of CGM (≥6 days/week) was associated with lower mean HbA1c. Only 27% of users downloaded data from their device at least once per month, and ≤15% of users reported downloading their device at least weekly. Among participants who used CGM at baseline, 41% had discontinued within 1 year. CONCLUSIONS: CGM use is uncommon but associated with lower HbA1c in some age-groups, especially when used more frequently. Factors associated with discontinuation and infrequent use of retrospective analysis of CGM data should be considered in developing next-generation devices and education on CGM use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such phenomena question the accuracy and credibility of CGM and make patients less reactive to alarms and less willing to retain them activated or even continue to use CGM [ 43 , 55 ].”
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 1×
“occasional) use of CGM is associated with better glycemic control, as measured by HbA1c (5,8), leading to a practice guideline recommending CGM for adults who are able to use it at least 6 days a week (9).”
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 490
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citationThe effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Items 301–338 of 338
Teló, G. H. (2016) · Americanae (AECID Library)
Aguilera, E., & Vázquez, F. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.02.008
Parkin, C. G. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0241
Continuous Glucose Monitoring: An Overview for Nurse Practitioners
Neeley, C., & Freeborn, D. (2018) · ScholarsArchive (Brigham Young University)
Aljawarneh, Y. M. (2018) · Digital Commons-TMC (Texas Medical Center)
Artificial pancreas development in type 1 diabetic patients
Boscari, F. (2018) · Padua@research (University of Padova)
Autosurveillance glycémique : objectifs de glycémie, objectifs d’HbA1c
Bismuth, É., & Coutant, R. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74942-1.00013-6
Stefenon, P. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Clinical Studies on Efficacy of Continuous Glucose Monitoring
Cherubini, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-42806-8_4
Reducing the rates of diabetes across the United States
Coleman, M. D., & Davies, A. (2020) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2020.09.018
Tomaszewski, E. L. (2021) · D-Scholarship@Pitt (University of Pittsburgh)
Improving Patient Care in Young People With Type 1 Diabetes Using Advances in Technology
Burckhardt, M. (2021) · UWA Profiles and Research Repository (UWA) · doi:10.26182/yy7z-8p80
Schlüter, S., Freckmann, G., Wernsing, M., Rölver, K., Jördening, M., Holder, M., Heinemann, L., & Lange, K. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1492-5294
Leuw, E. (1993) · Data Archiving and Networked Services (DANS)
Reynaud, R., Bendelac, N., & Coutant, R. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74942-1.00009-4
MESA 2: INNOVACIONES TECNOLÓGICAS EN EL TRATAMIENTO DE LA DIABETES MELLITUS TIPO 1
Morosini, M. L. R., PROIETTI, A. E., Ré, M., Schindler, A., Medek, G., Dios, A. D., Larreburo, S. V., Mengoni, K., González, L. S., Méndez, J., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v49i3.634
Lameijer, A. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.1021051970
Method of insulin delivery does not affect perinatal outcomes with type 1 diabetes mellitus
Sobhani, N. C., Watson, K., Kannan, A., & Patzek, S. M. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101462
Integrating Nutrition Therapy, Blood Glucose Monitoring, and Continuous Glucose Monitoring
Lyons, L., Powers, M. A., & Austin, M. M. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580406482.ch22
Chenoweth, D. J., Palmer, B. A., Norris, A. W., Tansey, M., & Pinnaro, C. T. (2024) · Pediatric Diabetes · doi:10.1155/2024/5218915
“These reports aid patients in making informed changes to their insulin doses, resulting in improved hemoglobin A1c (HbA1c) and quality of life [6, 7].”
Glycemic Goals and Assessment of Glycemia
(2022) · American Diabetes Association eBooks · doi:10.2337/9781580407700.ch02
Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients
Andellini, M., Schiaffini, R., Angelini, M., Pecchia, L., & Ritrovato, M. (2025) · Children · doi:10.3390/children12081088
“…studies investigating HbA1c variation associated with the use of CGM [12,22,23,27–32], four showed improvements in glycaemic control [23,28,32,33], five showed improvement in glycaemic control among consistent CGM users [12,22,27,30,32], and one found no statistically significant changes…”
Ćirić, V. (2023) · National Repository of Dissertations in Serbia
Aktuelles: Insulintherapie unter Bezugnahme auf die Leitlinienempfehlungen der ÖDG 2016
Lechleitner, M. (2016) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Felizardo, V. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Föchterle, S. (2020) · University Library Linz repository (Johannes Kepler Universitat Linz)
Kondo, T., Senokuchi, T., Yano, M., Takeda, H., Nishida, K., Kai, Y., & Kubota, N. (2026) · Diabetes Technology and Obesity Medicine · doi:10.1177/29986702261432849
Hayashi, S., Konaka, K., & HAMADA, R. (2026) · Cureus · doi:10.7759/cureus.107766
Why glycemic control remains suboptimal in type 1 diabetes in the era of advanced technologies?
Joubert, M. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101763
Granular Hydrogel Composites for Noninvasive Optical Biosensing
Williams, T. J., Saleem, W., Ahn, S., Chimene, D., McShane, M. J., & Alge, D. L. (2026) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.70121
Continuous Glucose Monitoring in Children and Adolescents With Type 2 Diabetes: A Narrative Review
O'Brien, C., Sethi, K., & Peña, A. S. (2026) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.70525
O'Neill, T., McTague, K., Begley, T., Banka, P., & Hollywood, E. (2026) · JBI Evidence Synthesis · doi:10.11124/jbies-25-00511
Current breakthroughs in real-time glucose tracking devices for diabetes
Sanagarapu, P. (2025) · Journal of Integral Sciences
Gil-Poch, E. (2025) · Institutional Repository University of Extremadura (University of Extremadura)
Elbalshy, M. (2024) · Otago University Research Archive (University of Otago)
AI-Enhanced Wearable Glucose Sensors: From Intelligent Sensing to Closed-Loop Management of Diabetes
Sun, B., Ling, L. L., Talip, M. S. B. A., Zheng, S., Fu, Y., Ma, Q., Rezali, F. A. M., Cheng, C., Yilin, P., & Hatta, S. F. W. M. (2026) · ACS Sensors · doi:10.1021/acssensors.6c02471
贾颖, & Liu, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1991652
Metadata
- Authors
- Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., Kleis, L., Chase, H. P., DuBose, S. N., Miller, K. M., Beck, R. W., Adi, S., & for the T1D Exchange Clinic Network
- Affiliations
- University of California, San Francisco (US)
- Jaeb Center for Health Research (US)
- University of Colorado Denver (US)
- Park Nicollet Health Services (US)
- Oregon Health & Science University (US)
- University of Southern California (US)
- Atlanta Diabetes Associates (US)
- Northwestern University (US)
- University of Washington (US)
- Spectrum Health (US)
- Corresponding author
- Miller, Kellee M.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2702-2709
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4392936
- OpenAlex
- W2136450455
- Semantic Scholar
- a3013d7ae63769a7d02f5f5ea02fd388f34dfe01
- Cited by
- 318
- References
- 19
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 27 · 2020: 33 · 2019: 38 · 2018: 45 · 2017: 35 · 2016: 32 · 2015: 29 · 2014: 2
- FWCI
- 26.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (5k12dk094726-05, UL1TR000142)
- National Institute of Diabetes and Digestive and Kidney Diseases (K12-DK094726)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- continuous glucose monitoring, type 1 diabetes, HbA1c, severe hypoglycemia, diabetic ketoacidosis, insulin pump, socioeconomic factors, age differences
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Patient Education as Topic, Registries, Retrospective Studies, Risk Factors, Blood Glucose Self-Monitoring, Incidence, Diabetic Ketoacidosis, Monitoring, Ambulatory, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.